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Abstract: OBJECTIVE: Keratocystic odontogenic tumor (KOT) is an 
odontogenic neoplasm that shows aggressive clinical behavior and local 
invasiveness. Invadopodia are actin-rich cellular protrusions exhibiting 
proteolytic pericellular activity, thereby inducing focal invasion in 
neoplastic cells and increasing neoplasms aggressiveness. Thus, this 
study aimed to evaluate immunoexpression of invadopodia-related proteins, 
cortactin, MT1-MMP, Tks4, and Tks5 in KOT. 
STUDY DESIGN: Immunohistochemistry of 16 cases of KOT, 8 cases of 
calcifying cystic odontogenic tumor (CCOT) and 8 samples of oral mucosa 
(OM) was carried out to assess the expression of the above described 
invadopodia-related proteins in the basal and suprabasal layer.  
RESULTS: KOT samples showed higher and significant immunoexpression of 
cortactin, MT1-MMP, TKs4 and TKs5 compared with CCOT and OM samples. 
Significant expression of all these proteins was observed in the basal 
layer when compared to the suprabasal layer in KOT. 
CONCLUSIONS: Overexpression of cortactin, MT1-MMP, TKs4 and TKs5 was 
observed in KOT when compared to samples of CCOT and OM. These proteins 
were also overexpressed in the basal over the suprabasal layer of KOT 
samples. Taken together, these results suggest the participation of 
invadopodia-related proteins on the pathogenesis of this lesion.  
 
 
 
 
 
 
Statement of Clinical Relevance 
Invadopodia are membrane protrusions present in tumor cells associated to aggressive 
behavior. Invadopodia-related proteins, cortactin, MT1-MMP, Tks4 and Tks5 were 
overexpressed in KOT. These results suggest invadopodia activity in KOT clinical 
behavior, increasing its aggressiveness. 
 
*Statement of Clinical Relevance (max 40 words)
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Title: Keratocystic odontogenic tumor overexpresses invadopodia-related proteins 
suggesting invadopodia formation. 
ABSTRACT 
OBJECTIVE: Keratocystic odontogenic tumor (KOT) is an odontogenic neoplasm 
that shows aggressive clinical behavior and local invasiveness. Invadopodia are actin-
rich cellular protrusions exhibiting proteolytic pericellular activity, thereby inducing 
focal invasion in neoplastic cells and increasing neoplasms aggressiveness. Thus, this 
study aimed to evaluate immunoexpression of invadopodia-related proteins, cortactin, 
MT1-MMP, Tks4, and Tks5 in KOT. 
STUDY DESIGN: Immunohistochemistry of 16 cases of KOT, 8 cases of calcifying 
cystic odontogenic tumor (CCOT) and 8 samples of oral mucosa (OM) was carried 
out to assess the expression of the above described invadopodia-related proteins in the 
basal and suprabasal layer.  
RESULTS: KOT samples showed higher and significant immunoexpression of 
cortactin, MT1-MMP, TKs4 and TKs5 compared with CCOT and OM samples. 
Significant expression of all these proteins was observed in the basal layer when 
compared to the suprabasal layer in KOT. 
CONCLUSIONS: Overexpression of cortactin, MT1-MMP, TKs4 and TKs5 was 
observed in KOT when compared to samples of CCOT and OM. These proteins were 
also overexpressed in the basal over the suprabasal layer of KOT samples. Taken 
together, these results suggest the participation of invadopodia-related proteins on the 
pathogenesis of this lesion.  
KEYWORDS: Keratocystic odontogenic tumor; odontogenic tumors; invadopodia; 
cortactin; membrane type I matrix metalloproteinase (MT1-MMP); Tks4; Tks5. 
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INTRODUCTION 
Keratocystic odontogenic tumor (KOT) is a benign odontogenic epithelial 
neoplasm with aggressive clinical behavior.
1-4
 The local aggressiveness of KOT has 
been related to many characteristics, including the biological behavior of its 
neoplastic epithelial cells,
4
 and genetic and epigenetic alterations
3,5
. For instance, 
studies have found evidence of allelic loss mainly in p16, p53, PTCH, MCC, TSLC1, 
LTAS2 and FHIT genes in KOT lesions.
3,5
 Some studies have attempted to identify 
the role of different molecules that can influence the clinical behavior of odontogenic 
tumors,
4,6,7
 however a full understanding regarding the mechanism related to KOT 
pathological behavior remains unknown. 
KOT is characterized by a well-defined basal layer of columnar or cuboidal 
cells, with intense nuclear basophilia with polarity inversion.  A thin capsule of 
connective tissue with few inflammatory cells and layers of parakeratin can also be 
found.
2,4,8,9
 The basal layer sometimes shows a bud-shaped proliferation that may lead 
to the formation of daughter lesions.
4,8-12
 KOT recurrence is a clinical challenge and 
occurs in nearly 23% of cases.
2
 This high recurrence rate may be due to an increased 
proliferative activity observed in KOT, revealed by overexpression of proliferation 
markers such as Ki67 and proliferating cell nuclear antigen (PCNA) in KOT 
compared to other odontogenic cysts and tumors.
3,8
 
A previous study has demonstrated the overexpression of matrix 
metalloproteinase-9 (MMP-9), epidermal growth factor (EGF) and tumor growth 
factor-alpha (TGF-α) in KOT cells.4 Thus, it was inferred that elevated MMP-9, EGF 
and TGF-α levels could promote ECM degradation and release of more growth 
factors, contributing to KOT aggressiveness.
4
 However, the mechanism of focal 
invasion of this tumor remains unknown.            
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Neoplastic cells invasion involves the dissemination of tumor cells from a 
primary site to the surrounding tissues.
13
 Among the mechanisms that mediate this 
process, invadopodia formation and its proteolytic activity over ECM molecules are 
of great importance.
14,15
 Invadopodia are actin-rich membrane protrusions that arise 
from the ventral surface of neoplastic cells and are vertically extended towards 
ECM.
16-18
 It is known that different proteins are related to invadopodia formation and 
activity.
19
 Among those molecules, cortactin and membrane-type 1 matrix 
metalloproteinase (MT1-MMP) are recognized as pivotal players in invadopodia 
formation, which are induced by Tks5 and Tks4 respectively.
14,19-23
 
 Cortactin is responsible for the regulation of actin polimerization and is 
involved in the initial steps of invadopodia formation.
24,25
 MT1-MMP is a 
transmembrane metalloprotease that plays a major role in the extracellular matrix 
remodeling and is strongly associated with neoplastic growth.
18
 These invadopodia-
related structural modifications of the cytoskeleton are mediated by the interaction of 
membrane receptors with the extracellular matrix, a process that may activate Src 
family proteins, such as Tks4 and Tks5. Tks molecules are adaptor proteins that are 
normally distributed throughout the cytoplasm but tend to be localized in the plasma 
membrane in pathological conditions.
25
 Tks5 has an important role in invadopodia 
elongation and is associated to cortactin.
26,27
 Tks4, in turn, is responsible for 
regulating MT1–MMP localization, secretion and stabilization,21,25 promoting 
localized ECM proteolysis and mediating tumor invasion.
14
 
  Tks family members are found in many tissues and play several roles in 
different physiological processes. However, Tks4 and Tks5 are markedly 
overexpressed in invasive cancers cells and are associated with higher 
aggressiveness.
20,27,28
 High levels of cortactin and MT1-MMP have already been 
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reported in ameloblastoma, an aggressive odontogenic neoplasm with local 
invasiveness and high recurrence rates.
18
 This finding prompted us to assess whether 
invadopodia markers would be expressed in KOT. The presence of invadopodia 
proteins in KOT could provide important information regarding its pathological 
behaviour. Two control groups were used in this study, the calcifying cystic 
odontogenic (CCOT), a non-aggressive odontogenic neoplasm selected due to its 
indolent behavior and low recurrence rates
4,6,18
 and samples of the health oral mucosa. 
 
MATERIALS AND METHODS 
SAMPLE SELECTION AND CLASSIFICATION 
Sixteen cases of KOT were retrieved from the files of the Department of Oral 
Pathology at the School of Dentistry, University Center of Pará - CESUPA (Belem, 
PA, Brazil). Eight cases of each control group were included in this study, which 
included samples of normal oral mucosa and the cystic variant of CCOT, the last 
chosen due to its similar odontogenic ectomesenchyme origin and distinct and 
indolent behavior, characterized by limited growth and low recurrences rates
4,6,18
.  All 
samples were evaluated by two oral pathologists and only those that showed a well 
preserved basement membrane length of ≥8 millimetres (mm)29,30 and fulfilled the 
histological profile of KOT and CCOT
2
 were included in this study. Non-
representative cases of both lesions and those that didn’t reach the required basement 
membrane length were excluded. This study was approved by the Ethics Committee 
of the Institute of Health Sciences at Federal University of Pará (0084.0.073.000-10). 
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IMMUNOHISTOCHEMISTRY 
Formalin-fixed, paraffin-embedded tissues were studied by 
immunohistochemistry. Three-micron sections were obtained and mounted on poly-
D-lysine-coated slides (Sigma Chemical Corp., St Louis MO, USA). Sections were 
dewaxed in xylene and rehydrated in graded ethanol. Antigen retrieval was carried out 
in Pascal chambers (Dako, Carpinteria, CA, USA) for 30 seconds. Sections were 
immersed in 3% H2O2 in methanol for 20 minutes for the inhibition of endogenous 
peroxidase activity and then blocked with 1% bovine serum albumin (BSA, Sigma®) 
in phosphate-buffered saline (PBS) for 1 hour. The slides were incubated with 
primary antibodies anti-cortactin (1:200, rabbit, Santa Cruz Biotechnology, CA, 
USA), anti-Tks5 (1:100, goat, Abcam, Cambridge, MA, USA), anti-Tks4 (1:100, 
rabbit, Abcam) and anti-MT1-MMP (1:50, mouse, R&D systems, Minneapolis, MN, 
USA). All primary antibodies were diluted in antibody diluent solution (Dako®) and 
incubated for 1 hour at room temperature. Subsequently, sections were incubated for 
30 minutes with the biotin-free horseradish peroxidase (HRP)-labeled polymer of the 
LSAB Detection System (Dako®). Diaminobenzidine (Sigma®) was used as a 
chromogen, and the sections were counterstained with Mayer's hematoxylin 
(Sigma®). Replacement of specific primary antibodies with non-immune sera served 
as negative control and samples of oral squamous cell carcinoma were used as 
positive control (data not shown).  
INFLAMMATORY AND IMMUNOSTAINING EVALUATION 
Brightfield images from ten randomly selected images from each sample were 
acquired using an Axioskop 40 microscope (Carl Zeiss, Germany) equipped with a 
CCD color camera (AxiocCam MRc, Carl Zeiss). All images were acquired at the 
same magnification (400x). The basement membrane was measured using the 
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8 
freehand line tool of the software ImageJ (public domain software developed by 
Wayne Rasband - NIMH, NIH, Bethesda, MD, USA, http://rsbweb.nih.gov/ij/). The 
inflammation score was assessed by counting the total number of inflammatory cells 
adjacent to the epithelium in all 10 images. Inflammation assessment was carried out 
in grades, being Grade 0 - no inflammation, Grade 1 - <15 cells/field, Grade 2 - 15-50 
cells/field, and Grade 3 - >50 cells/field. The inflammatory score was calculated as 
the average of all fields examined. Samples of KOT, CCOT and OM were divided 
into two groups according to the inflammatory score: group A - grades 0-2 (mild-to-
moderate) and group B - grade 3 (intense).
31
 Comparison of the inflammation grades 
between group A and B and the immunoexpression of cortactin, MT1-MMP, Tks4, 
and Tks5, in basal and suprabasal layers were conducted for each tissue. 
Immunostaining analysis was carried out for cortactin, MT1-MMP, Tks4, and 
Tks5. Areas of diaminobenzidine staining were separated and segmented using the 
color deconvolution plug-in of ImageJ. After image deconvolution, the epithelial area 
was assessed in two different segments that corresponded to the basal and suprabasal 
layers. Results were expressed as the average percentage of stained area (%) of the 
epithelial neoplastic tissue after adjusting for the correspondent basement membrane 
length. Differences in the percentages of stained areas for the basal and suprabasal 
epithelial layers of KOT, CCOT and OM were quantified. Image acquisition and 
measurement of diaminobenzidine staining were blinded before quantification by the 
examiner.  
STATISTICAL ANALYSIS 
Data were analyzed using the Graph Pad Prism 6 software (Graph Pad 
Software, Inc., San Diego, CA, USA). Differences between the three groups of 
samples were assessed using one-way ANOVA followed by the Tukey’s multiple 
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9 
comparison test. The parametric unpaired two-tailed t-test was used to analyze the 
differences between the basal and suprabasal layers. All tests were set to 95% 
confidence interval. 
RESULTS 
 The length of the basement membrane varied from 8.01 mm to 23.45 mm, 
with the mean length of 9.22 mm in KOT, 9.76 mm in CCOT and 13.54 mm in OM. 
No cases presented inflammation grade 0, with inflammatory cells found in all 
samples. The summary of these results can be seen in Table I.  
KOT and CCOT immunoexpress cortactin, MT1-MMP, Tks4 and Tks5 
Cortactin, MT1-MMP, Tks4, and Tks5 were expressed in all KOT and CCOT 
samples. The oral mucosa showed low expression of cortactin, MT1-MMP and very 
low expression of Tks4 and Tks5. KOT neoplastic cells showed cytoplasmic 
expression of cortactin as dots in the epithelial basal and suprabasal layers. (Fig 1A). 
CCOT also expressed cortactin with a similar immunolocalization (Fig 1B). Small 
blood vessels and inflammatory cells were also positively stained for cortactin. 
Expression of this protein was not constant in the OM and usually found in the basal 
layer of samples (Fig 1C). Comparative analyze showed differences between the three 
groups, with the highest expression found in KOT, followed by CCOT and OM (Fig. 
1D). 
Cytoplasmic staining was also observed for MT1-MMP in KOT and CCOT 
neoplastic cells (Fig 2A-B). A weak cytoplasmic staining of MT1-MMP was found in 
the OM, which was reduced compared to both odontogenic tumors (2C). 
Inflammatory and endothelial cells were found to express MT1-MMP, specially in 
KOT and CCOT. MT1-MMP immunolocalization appeared to be more intense near to 
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10 
the basement membrane in KOT. No difference was observed in the suprabasal layer 
between KOT and CCOT (2D).  
Tks4 was immunostained with a granular pattern in the cytoplasm of KOT and 
CCOT (Fig. 3A-B). Tks4 showed a more intense expression in the basal layer in KOT 
and a discrete presence in the upper cells of the suprabasal layer in CCOT (Fig. 3A-
B). Stromal cells expressed TKs4, which was poorly or even non-expressed in OM 
samples (Fig. 3C).  Statistical analysis showed difference between KOT and the other 
samples in basal and suprabasal layers, but no difference was detected between CCOT 
and OM (Fig. 3D). 
Similar to all the other proteins studied here, a cytoplasmic granular pattern of 
staining was found for Tks5. In KOT, Tks5 immunostaining was more intense in the 
basal layer and constantly expressed in all samples (Fig. 4A).  The expression of Tks5 
in CCOT was low, specially in the suprabasal layer (Fig. 4B). Expression of this 
protein in OM was very low (Fig. 4C). Statistical deference was found between the 
three tissues in both layers (Fig. 4D). 
 Although the CCOT samples also expressed cortactin, MT1-MMP, Tks4, and 
Tks5, the overall expression of these proteins were reduced in CCOT and OM 
compared to KOT.  
 In order to evaluate if there are differences between the expression of 
invadopodia-related proteins in the basal and suprabasal layer, a comparison of the 
expression of all proteins between these two layers was conducted. In comparison to 
OM tissue cortactin, MT1-MMP, Tks4, and Tks5 were all overexpressed in the basal 
layer of KOT samples, while no differences were observed in CCOT (Fig. 5). The 
potential role of inflammation in the expression of cortactin, MT1-MMP, Tks4 and 
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Tks5 was assessed by comparing the basal and suprabasal layers of group A (mild-to-
moderate) and group B (intense) for each tissue. The level of tissue inflammation had 
no affect on the expression levels of cortactin, MT1-MMP, Tks4, and Tks5 in any 
tissue. These results are summarized in Table I. 
DISCUSSION 
 Increased expression of cortactin and MT1-MMP has been related to 
aggressive behavior of various malignancies.
14,15
 These proteins participate in 
invadopodia assembly. Invadopodia are membrane protrusions that allow neoplastic 
cells promote focal invasion. Membrane protrusions are driven by cortactin, while 
MT1-MMP is a key molecule for pericellular focal proteolysis. Cortactin and MT1-
MMP are regulated by the Scr-kinases, Tks5 and Tks4 respectively. Our results 
showed overexpression of invadopodia-related proteins cortactin, MT1-MMP, Tks4, 
and Tks5 in KOT compared to CCOT and OM. All proteins were only expressed in 
the cytoplasm, with an increased expression in the basal layer of KOT samples, which 
strongly suggest the formation of invadopodia in this lesion. Low or no expression of 
invadopodia-related proteins was expected in OM, because of its non-pathologic 
nature. 
Cortactin is one of the molecules responsible for actin polymerization, a 
pivotal event related to invadopodia formation.
14,22,23
 Our results showed that 
cortactin was distributed in KOT neoplastic cells cytoplasm and mostly outlining the 
cell edges.  Those finding were expected, since cortactin concentrates at the cell 
membrane to initiate invadopodia assembly.
19,24,25,32
 In addition, cortactin can bind to 
actin-related molecules like N-WASp and Arp2/3, forming complexes that may 
possibly function as bridges to Tks5 in the initial steps of invadopodia formation.
20,33-
35
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Scr-kinases Tks4 and Tks5, also have an important role in invadopodia 
formation acting as promoters of these structures.
25,36-39
  Our results demonstrated that 
both Tks4 and Tks5 showed elevated cytoplasmic expression in KOT neoplastic cells. 
Both molecules have a N-terminal Phox (PX) and SH3 domains, which after tyrosine 
phosphorylation, promote invadopodia formation and function.
25,37-39
 Tks5 regulates 
actin cytoskeleton and cell membrane remodeling.
22,23,37
 Tks4, recruits MT1-MMP, 
leading to focal MMP activity and ECM degradation, which in turn results in 
invadopodia maturation and stabilization.
19,22,25,38
  
Elevated MT1-MMP levels in KOT cells was localized to the neoplastic cells 
cytoplasm. MT1-MMP is a transmembrane metalloproteinase responsible for 
pericellular matrix degradation.
14
 MT1-MMP inhibition does not impair invadopodia 
formation but inhibits matrix degradation, probably due to a failure in MT1-MMP-
mediated MMPs 2 and 9 local release.
14
 The proteolytic activity of KOT neoplastic 
cells is reinforced here; with an elevated expression of MT1-MMP, which is 
supported by our previous result that demonstrated high levels of MMP-9 in KOT 
cells.
4
 
KOT is known to be an intraosseous uni- or multicystic neoplasm, which may 
present daughter lesions.
3,8,10,39
 These daughter lesions occur sporadically for 
unknown reasons. Our hypothesis is that invadopodia may take part in this process 
because of its ability to promote focal invasion. Invadopodia pericellular activity 
could induce detachment of one or more neoplastic cells from the primary lesion, 
leading to the formation of daughter lesions, and this event would be supported by 
overexpression of invadopodia-related proteins demonstrated in this study.  
Another possible consequence of invadopodia influence in KOT clinical 
behavior could be related to the irregular pattern of growth sometimes presented by 
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this tumor. As a cystic lesion, KOT growth should occur relatively regularly, similar 
to other odontogenic cysts like dentigerous or radicular cysts, but this is often not the 
case.
40
 KOT usually grows as multi-cystic lesions with irregular borders.
41
 
Radiological features of KOTs with irregular and poorly defined edges suggest a 
distinct pattern of growth in different parts of the same neoplasm. Those localized 
differences could be influenced by different invadopodia-related bone degradation in 
distinctive areas of this neoplasm. 
Finally, it is already known that epidermal growth factor (EGF) and epidermal 
growth factor receptor (EGFR) induces invadopodia formation.
7,15,17,35,40,42,43
 These 
molecules are overexpressed in KOT in accordance with our previous results.
4
 
Although the limitations do not allow us to conclude that invadopodia are present in 
KOT, overexpression of their main associated proteins strongly suggests that they are. 
This speculation remains to be further elucidated. 
The formation and function of invadopodia are directly related to the presence 
of two main proteins, cortactin and MT1-MMP, and are reinforced by high expression 
of their inducers Tks5 and Tks4.
14
 All four proteins were found to be overexpressed in 
KOT and localized to the basal layer were the invasion mechanisms occurs. 
Interestingly, inflammation had no influence on the expression of these proteins in 
any of the samples. Our data suggest that invadopodia may be present and would 
influence KOT clinical behavior.  
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Figure Legends   
Fig. 1 Cortactin immunostaining in KOT, CCOT and OM samples. Cortactin was 
found in the cytoplasm of epithelial basal cells and in the cells of the upper stratum 
(A). A strong staining was observed in the basal layer, predominantly outlining cell 
edges. CCOT also expressed cortactin in a similar pattern but with less intensity (B). 
The overall cortactin expression in the OM was low (C). Significant difference was 
found between these 3 tissues in basal and subrabasal layers (D). Magnification 630X. 
Scale bars: 20µm. *=p<0.05; **=p<0.01; ***= p < 0.001; ****= p< 0.0001. 
 
Fig. 2 MT1-MMP immunostaining in KOT, CCOT and OM samples. MT1-MMP was 
found in the cytoplasm of KOT cells (A). A more intense immunolocalization of this 
protein was found near to the basement membrane in the basal layer of KOT. 
Although CCOT also expresses MT1-MMP, this expression appears to be lower 
compared to KOT (B). The expression of MT1-MMP was weaker in OM samples (C). 
KOT immunoexpresses higher amount of MT1-MMP (D). Magnification 630X. Scale 
bars: 20µm. *=p<0.05; **=p<0.01; ***= p < 0.001; ****= p< 0.0001. 
 
Fig. 3 TKs4 immunostaining in KOT, CCOT and OM samples. TKs4 was expressed 
in the cytoplasm of KOT with an higher intensity in the layer with a granular form 
(A). CCOT also expressed TKs4, but with a very low expression in the suprabasal 
layer (B). Tiny amount of Tks4 expression was found in OM samples (C). Statistical 
analysis showed differences between KOT and the other samples, but no differences 
between CCOT and the OM (D). Magnification 630X. Scale bars: 20µm. *=p<0.05; 
**=p<0.01; ***= p < 0.001; ****= p< 0.0001. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
22 
Fig. 4 TKs5 immunostaining in KOT, CCOT and OM samples. Similar cytoplasmic 
granular pattern of TKs5 staining, with higher intensity in the basal layer was found in 
KOT (A). CCOT showed a similar pattern but with equivalent distribution between 
the basal and suprabasal layers (B). Immunoexpression of Tks5 was very low in the 
OM (C). Statistical analysis demonstrated differences in the basal and suprabasal 
layers of all tissues, with higher expression in KOT (D). Magnification 630X. Scale 
bars: 20 µm. *=p<0.05; **=p<0.01; ***= p < 0.001; ****= p< 0.0001. 
 
Fig 5 Comparison between Cortactin, TKs5, MT1-MMP and TKs4 immunostaining 
in the basal and suprabasal layers in the same samples. Statistical differences were 
observed with higher expression in the basal layer in KOT for all proteins (A). No 
differences were found between these two layers in CCOT (B). The OM also showed 
higher expression of these proteins in the basal membrane, except for Tks5. The 
overall expression of Src-kinases Tks4 and Tks 5 was very low (C). Significance: 
*=p<0.05; **=p<0.01; ***= p < 0.001; ****= p< 0.0001. 
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Table I: Length of the basement membrane and inflammation assessment. 
 
Length of basement membrane (mm) Inflammation grade 
Mean Min Max SD 0 1 2 3 A x B 
KOT 9.220 8.029 11.484 0.834 - 8 4 4 ns 
CCOT 9.759 8.026 15.213 1.513 - 2 3 3 ns 
OM 13.537 8.006 23.451 3.904 - 5 2 1 ns 
Abbreviation: KOT, keratocystic odontogenic tumor; CCOT, calcifying cystic 
odontogenic tumor; OM, oral mucosa; SD, standard deviation; 
A x B describe the summary of statistical analysis for cortactin, membrane-type 1 
matrix metalloproteinase, Tks4 and Tks5 between A, inflammation assessment 
Group A - grades 0-1 (mild-to-moderate) and B, inflammation assessment group 
B - grade 3 (intense); ns, non-significant; 
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